Faeth Therapeutics (FTH) Price to Book (2021 - 2026)

Faeth Therapeutics (FTH) has reported Price to Book for 6 consecutive years, with 0.82 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Price to Book rose 105.88% year-over-year to 0.82; the trailing twelve-month figure through Jun 2026 stood at 0.82 (up 105.88% YoY), and the FY2025 full-year result was 0.72, down 88.74% from the prior year.
• Price to Book grew to 0.82 in Q2 2026 per FTH's latest filing, from 0.31 in the prior quarter.
• Across five years, Price to Book topped out at 11.08 in Q2 2022 and bottomed at 0.31 in Q1 2026.
• Historically, Price to Book has averaged 5.75 across 5 years, with a median of 6.32 in 2024.
• The widest YoY moves for Price to Book: up 105.88% in 2026, down 104.96% in 2026.
• Over 5 years, Price to Book stood at 8.87 in 2022, then slumped by 39.79% to 5.34 in 2023, then increased by 20.43% to 6.43 in 2024, then plunged by 88.74% to 0.72 in 2025, then climbed by 12.65% to 0.82 in 2026.
• According to Business Quant data, Price to Book over the past three periods registered 0.82, 0.31, and 0.72 for Q2 2026, Q1 2026, and Q4 2025 respectively.